NIFTY 50
23,851.65 (1.77%)
NIFTY IT
33,372.35 (0.23%)
NIFTY AUTO
21,373.10 (1.03%)
NIFTY FINANCIAL SERVICES
26,071.60 (2.27%)
NIFTY BANK
54,290.20 (2.21%)
NIFTY REALTY
845.10 (0.51%)
NIFTY ENERGY
33,797.50 (1.02%)
NIFTY METAL
8,476.50 (0.26%)
NIFTY FMCG
56,674.20 (0.58%)
NIFTY HEALTH CARE
13,711.05 (1.16%)
NIFTY PHARMA
21,126.75 (1.21%)
NIFTY MEDIA
21,126.75 (1.21%)
Platforms
Mobile Application
Web Trading
Desktop Application
Insights
Research
Videos
Markets
Equity
Derivatives
IPO
Other Markets
Corporate Information
Pricing
Support
Login
Open an Account
Home
Platform
Insights
Research
Markets
Pricing
Support
Login
Open an Account
Trend of Stock Market
A trend is the broad upward or downward movement of a stock's price over time
Forthcoming IPO
Open Issues
Closed Issue
Top Gainers / Losers
52 Weeks High/ Low
Value / Volume Toppers
Get Quotes
Nifty Futures
Top Traded Quantity
Top Traded Value
Derivative Summary
Daily Settlement Price
List Of Underlying
Put Call Ratio
FII Statistics
Most Active Contract
All Index Futures
Top Gainers
Top Losers
Highest In OI
Lowest In OI
Increase In OI
Decrease In OI
Most Active Calls
Most Active Put
Top Gainers
Top Losers
Highest In OI
Lowest In OI
Increase In OI
Decrease In OI
Forthcoming Issues
Open Issues
Closed Issue
World Indices
ADR Prices
MF Investment
FII Investment
Get Quotes
Company Snapshot
Company Background
Board of Directors
Directors Reports
Profit & Loss
Balance Sheet
Quarterly Results
Shareholding Pattern
Key Financial Ratios
Mutual Fund Holdings
Peer Comparison
Technical Chart
Company News
Change Company Name
Suven Pharmaceuticals Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
543064
ISIN Demat
INE03QK01018
Book Value
86.66
NSE Symbol
SUVENPHAR
Dividend Yield (%)
0
Market Cap (
₹
Cr.)
29,729.37
P/E
105.69
EPS
11.05
Face Value
1
Date
Headline
27-Mar-25
Suven Pharmaceuticals to table results
28-Feb-25
Suven Pharmaceuticals receives credit ratings from CRISIL
28-Dec-24
Suven Pharmaceuticals schedules board meeting
23-Dec-24
Suven Pharmaceuticals acquires 56% stake in NJ Bio Inc.
07-Dec-24
Suven Pharmaceuticals to acquire majority stake in US based NJ Bio
30-Oct-24
Suven Pharmaceuticals to conduct EGM
27-Sep-24
Suven Pharmaceuticals to convene board meeting
19-Sep-24
Board of Suven Pharmaceuticals approves change in Executive Chairperson
06-Aug-24
Suven Pharmaceuticals to hold board meeting
15-Jul-24
Suven Pharmaceuticals to conduct AGM
Prev
1
2
3
Next